TotalMarketCap

ADC Therapeutics

ADCTNYSE SwitzerlandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$207.460 M

$1.63 -5.52%

Close of 6 Nov 2026

As of 6 Nov 2026, ADC Therapeutics (ADCT) has a market capitalization of $207.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$81.4M

#2558 by revenue

Earnings

-$142.6M

Loss-making

Shares outstanding

127,667,695

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #242Siga TechnologiesSIGA$213.0M
  2. #243AC ImmuneACIU$212.7M
  3. #244ADC TherapeuticsADCT$207.5M
  4. #245Sol-Gel TechnologiesSLGL$206.3M
  5. #246Cartesian TherapeuticsRNAC$205.2M

What if ADC Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$221,174.78

Per share 136,108× higher

Bitcoin $1.53T

$11,967.38

Per share 7,365× higher

Apple $5.02T

$39,287.80

Per share 24,177× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for ADC Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.